Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

23

Revenue 2014

Biogen Idec

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Biogen Idec's 2013 Oncology and CNS sales performance.

EP downgrades long-term sales projections for pharma

EP downgrades long-term sales projections for pharma

Biogen's aducanumab for Alzheimer's disease - although clearly a high-risk candidate - and Johnson &Johnson's prostate cancer therapy apalutamide, which is due to be filed later this year.

Novo Nordisk wins European approval for Refixia

Novo Nordisk wins European approval for Refixia alfa) from Biogen and Swedish Orphan Biovitrum which was approved in the EU last year.

Constellation Pharmaceuticals appoints Jigar Raythatha as CEO

Constellation Pharmaceuticals appoints Jigar Raythatha as CEO Previously, Raythatha has served as head of corporate development at Constellation, where he led business development, strategy and programme management functions and has held roles at Biogen, Red Abbey Venture Partners

Biogen wins European spinal muscular atrophy first

Biogen wins European spinal muscular atrophy first Biogen wins European spinal muscular atrophy first. Spinraza wins accelerated approval to treat patients with the most common form of SMA. ... Biogen now has approval in Europe to go with its US license for Spinraza, its drug for the genetic disease

HTA guidance from NICE, the SMC and the AWMSG

HTA guidance from NICE, the SMC and the AWMSG. Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

The new pharma marketing playbook
Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity
Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing
Achieve real health behaviour change by including these elements in your pharmaceutical marketing....

Infographics